Over-prescription of short-acting β₂-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study

Felicia Montero-Ariasa Servicio de Neumología, Hospital México, CCSS y Hospital Clínica Bíblica Santa Ana, San José, Costa RicaCorrespondence[email protected]
View further author information

, MD,

Jose Carlos Herrera Garciab Pulmonary Function Unit, Unidad de Funcion Pulmonar, Unidad de investigación Clínica de Puebla, UISP Unidad de Investigación y Salud de Puebla, Puebla, MexicoView further author information

, MD,

Manuel Pacheco Gallegoc Neumología, Unversidad Tecnológica de Pereira Y Fundación Universitaria Visión de las Américas. Respiremos S.A.S–Clinical Comfamiliar, Pereira, ColombiaView further author information

, MD, MHA, MSc,

Martti Anton Antilad Clinical Research/Allergy, Clínica de Alergia Martti Antila, São Paulo, BrazilView further author information

, MD,

Patricia Schonffeldte Especialista Médicina Interna y Enfermedades Respiratorias, Instituto Nacional del Tórax ITMS Telemedicina de Chile, Santiago, ChileView further author information

, MD,

Walter Javier Mattaruccof Neumonólogo, CEPROSS (Centro profesional San Salvador), Entre Rios, ArgentinaView further author information

, MD,

Luis Fernando Tejado Gallegosg Evidence Generation, AstraZeneca, Mexico City, MexicoView further author information

, MD, MPH, MHA &

Maarten J. H. I. Beekmanh Respiratory & Immunology, AstraZeneca, The Hague, The NetherlandsView further author information

, MD show all

Over-prescription of short-acting β₂-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study

Supplementary_material_CLEAN.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Over-prescription of short-acting β2-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study

Supplementary_material_CLEAN.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Over-prescription of short-acting β₂-agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study